21 results on '"Kang WQ"'
Search Results
2. WITHDRAWN: Case of renal artery thrombosis in a neonate
- Author
-
Guo, Jing and Kang, WQ
- Published
- 2021
- Full Text
- View/download PDF
3. [Comparing the prognostic value of 3 diagnostic criteria of bronchopulmonary dysplasia in preterm infants].
- Author
-
Wang X, Guo J, Wu YY, Lu YK, Liu DP, Li MC, Li R, Wang YY, and Kang WQ
- Subjects
- Infant, Male, Child, Infant, Newborn, Humans, Prognosis, Retrospective Studies, Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia diagnosis, Bronchopulmonary Dysplasia complications
- Abstract
Objective: To compare the prognostic value of 3 diagnostic criteria of bronchopulmonary dysplasia (BPD) in preterm infants with gestational age<32 weeks. Methods: The retrospective cohort study was conducted to collect the clinical data of 285 preterm infants with BPD admitted to the Department of Neonatology, Children's Hospital Affiliated to Zhengzhou University from January 2019 to September 2021, who were followed up regularly after discharge. The primary composite adverse outcome was defined as death or severe respiratory morbidity from 36 weeks of corrected gestational age to 18 months of corrected age, and the secondary composite adverse outcome was defined as death or neurodevelopmental impairment. According to the primary or secondary composite adverse outcomes, the preterm infants were divided into the adverse prognosis group and the non-adverse prognosis group. The 2001 National Institute of Child Health and Human Development (NICHD) criteria, 2018 NICHD criteria, and 2019 Neonatal Research Network (NRN) criteria were used to diagnose and grade BPD in preterm infants. Chi-square test, Logistic regression analysis, receiver operating characteristic (ROC) curve and Delong test were used to analyze the prognostic value of the 3 diagnostic criteria. Results: The 285 preterm infants had a gestational age of 29.4 (28.1, 30.6) weeks and birth weight of 1 230 (1 000, 1 465) g, including 167 males (58.6%). Among 285 premature infants who completed follow-up, the primary composite adverse outcome occurred in 124 preterm infants (43.5%), and the secondary composite adverse outcome occurred in 40 preterm infants (14.0%). Multivariate Logistic regression analysis showed that severe BPD according to the 2001 NICHD criteria, gradeⅡand Ⅲ BPD according to the 2018 NICHD criteria and grade 2 and 3 BPD according to the 2019 NRN criteria were all risk factors for primary composite adverse outcomes (all P< 0.05). ROC curve showed that the area under the curve (AUC) of the 2018 NICHD criteria and 2019 NRN criteria were both higher than that of the 2001 NICHD criteria (0.70 and 0.70 vs. 0.61, Z= 4.49 and 3.35, both P< 0.001), but there was no significant difference between the 2018 NICHD and 2019 NRN criteria ( Z= 0.38, P= 0.702). Multivariate Logistic regression analysis showed that the secondary composite adverse outcomes were all associated with grade Ⅲ BPD according to the 2018 NICHD criteria and grade 3 BPD according to the 2019 NRN criteria (both P< 0.05). ROC curve showed that the AUC of the 2018 NICHD criteria and 2019 NRN criteria were both higher than that of the 2001 NICHD criteria (0.71 and 0.71 vs. 0.58, Z= 2.93 and 3.67, both P< 0.001), but there was no statistically significant difference between the 2018 NICHD and 2019 NRN criteria ( Z= 0.02, P= 0.984). Conclusion: The 2018 NICHD and 2019 NRN criteria demonstrate good and comparable predictive value for the primary and secondary composite adverse outcomes in preterm infants with BPD, surpassing the predictive efficacy of the 2001 NICHD criteria.
- Published
- 2024
- Full Text
- View/download PDF
4. Comparison of two novel diagnostic criteria for bronchopulmonary dysplasia in predicting adverse outcomes of preterm infants: a retrospective cohort study.
- Author
-
Wang X, Lu YK, Wu YY, Liu DP, Guo J, Li MC, Wang Y, Li R, Zhang XY, and Kang WQ
- Subjects
- Infant, Newborn, Child, Infant, Humans, Child, Preschool, Retrospective Studies, Gestational Age, Birth Weight, Infant, Premature, Bronchopulmonary Dysplasia diagnosis
- Abstract
Background: This study aimed to compare the predictive value of two diagnostic criteria for bronchopulmonary dysplasia (BPD) in preterm infants with gestational age (GA) < 32 weeks for death or severe respiratory morbidity at corrected age of 18-24 months., Methods: In this retrospective cohort study, clinical data from July 2019 to September 2021 were classified by 2018 National Institute of Child Health and Human Development (NICHD) and 2019 Jensen definitions of BPD. Based on the follow-up results, the enrolled population was divided into adverse outcome group and normal outcome group. Logistic regression and receiver operating characteristic (ROC) curve analyses were conducted to explore the risk factors of adverse outcomes and evaluate the predictive value of both diagnostic criteria., Results: Of 451 infants, 141 (31.3%) had adverse outcomes, which increased with increasing severity of BPD. Logistic regression analysis showed only BPD was an independent risk factor for adverse outcomes in preterm infants. ROC analysis revealed that both diagnostic criteria showed similar predictive values (2018 NICHD definition AUC = 0.771 vs. 2019 Jensen definition AUC = 0.770), with specificities of 93.5% and 96.8%, respectively; however, combining them separately with GA or birth weight did not improve their predictive values., Conclusions: The two novel definitions of BPD demonstrate similar predictive values in predicting death or severe respiratory morbidity at corrected age of 18-24 months, with higher specificity observed in both., (© 2023. BioMed Central Ltd., part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
5. The mechanism study of inhibition effect of prepared Radix Rehmanniainon combined with Radix Astragali osteoporosis through PI3K-AKT signaling pathway.
- Author
-
Kang WQ, Wei PF, Ou L, Li M, and Liu CY
- Subjects
- Female, Rats, Animals, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Signal Transduction, Astragalus Plant chemistry, Drugs, Chinese Herbal pharmacology, Drugs, Chinese Herbal therapeutic use, Osteoporosis drug therapy
- Abstract
Purpose: To observe the mechanism of prepared Radix Rehmanniainon combined with Radix Astragali in treating osteoporosis., Methods: Osteoporosis rat model was established by bilateral ovariectomy combined with low-calcium diet feeding. Bone mineral density was measured by bone densitometer. Bone metabolism markers in serum were detected by enzyme linked immunosorbent assay (ELISA), bone tissue structure was observed by hematoxylin-eosin staining, and the effect of prepared Radix Rehmanniainon combined with Radix Astragali on PI3K-AKT signaling pathway was investigated by immunohistochemistry and reverse transcription polymerase chain reaction., Results: Compared with the model group, the bone tissue structure and imbalance of bone metabolism were improved, and the bone mineral density was significantly increased in the prepared Radix Rehmanniainon combined with Radix Astragali groups. After intervention with prepared Radix Rehmanniainon combined with Radix Astragali, the positive expression of PIK3CA and Akt1 in rat bone tissue was enhanced, and the expression levels of Akt1 mRNA were significantly increased., Conclusions: Prepared Radix Rehmanniainon combined with Radix Astragali may treat osteoporosis by activating PI3K/AKT pathway.
- Published
- 2023
- Full Text
- View/download PDF
6. Evaluation of the clinical effect of an artificial intelligence-assisted diagnosis and treatment system for neonatal seizures in the real world: a multicenter clinical study protocol.
- Author
-
Xiao TT, Dou YL, Zhuang DY, Hu XH, Kang WQ, Guo L, Zhao XF, Zhang P, Yan K, Yan WL, Cheng GQ, and Zhou WH
- Subjects
- Artificial Intelligence, Electroencephalography methods, Humans, Infant, Newborn, Intensive Care Units, Neonatal, Multicenter Studies as Topic, Prospective Studies, Randomized Controlled Trials as Topic, Seizures diagnosis, Seizures drug therapy, Epilepsy diagnosis, Infant, Newborn, Diseases diagnosis
- Abstract
Neonatal seizures are the most common clinical manifestations of critically ill neonates and often suggest serious diseases and complicated etiologies. The precise diagnosis of this disease can optimize the use of anti-seizure medication, reduce hospital costs, and improve the long-term neurodevelopmental outcomes. Currently, a few artificial intelligence-assisted diagnosis and treatment systems have been developed for neonatal seizures, but there is still a lack of high-level evidence for the diagnosis and treatment value in the real world. Based on an artificial intelligence-assisted diagnosis and treatment systems that has been developed for neonatal seizures, this study plans to recruit 370 neonates at a high risk of seizures from 6 neonatal intensive care units (NICUs) in China, in order to evaluate the effect of the system on the diagnosis, treatment, and prognosis of neonatal seizures in neonates with different gestational ages in the NICU. In this study, a diagnostic study protocol is used to evaluate the diagnostic value of the system, and a randomized parallel-controlled trial is designed to evaluate the effect of the system on the treatment and prognosis of neonates at a high risk of seizures. This multicenter prospective study will provide high-level evidence for the clinical application of artificial intelligence-assisted diagnosis and treatment systems for neonatal seizures in the real world.
- Published
- 2022
- Full Text
- View/download PDF
7. Prevention of neonatal ventilator-associated pneumonia through oral care with the combined use of colostrum and sodium bicarbonate.
- Author
-
Li DF, Shi CX, Zhao L, Shi FZ, Jiang ML, and Kang WQ
- Subjects
- Female, Humans, Infant, Newborn, Intensive Care Units, Neonatal, Pregnancy, Colostrum, Oral Hygiene, Pneumonia, Ventilator-Associated prevention & control, Sodium Bicarbonate pharmacology
- Abstract
Objective: This study aims to investigate the effect of oral care via the combined use of colostrum and sodium bicarbonate on the prevention of neonatal ventilator-associated pneumonia (VAP)., Patients and Methods: In accordance with the inclusion and exclusion criteria, 120 infant patients who were hospitalized in the neonatal intensive care unit (NICU) from January to October of 2019 were selected and randomly divided into three groups (40 cases in each group), namely, colostrum combined with sodium bicarbonate nursing (experimental group), colostrum (control group I), and sodium bicarbonate (control group II) groups. The primary outcomes measured included incidence rates of VAP and oral infection, positive rate of pathogenic bacteria after sputum culture, mechanical ventilation time, and length of stay (LOS)., Results: The incidence rates of VAP and oral infection and the positive rate of pathogenic bacteria after sputum culture of the experimental group, which were 6.67%, 10.00%, and 10.00%, respectively, were significantly different from those of control groups I and II (p < 0.05). The mechanical ventilation time of the experimental group was 156.07 ± 26.67 h, which was shortened by 9.79% and 9.43% compared with those of control groups I and II, respectively. The LOS of the experimental group was 17.6 ± 1.96 days, which was shortened by 17.74% and 17.50% compared with those of control groups I and II, respectively. The differences were statistically significant (p< 0.05)., Conclusions: Oral care through the combined use of colostrum and sodium bicarbonate can lower the VAP incidence rate of infant patients and shorten their mechanical ventilation time and LOS.
- Published
- 2021
- Full Text
- View/download PDF
8. Effects of simulation training on COVID-19 control ability and psychological states of nurses in a children's hospital.
- Author
-
Li DF, Shi CX, Shi FZ, Zhao L, Zhao R, and Kang WQ
- Subjects
- Adult, Anxiety prevention & control, Anxiety psychology, Betacoronavirus pathogenicity, COVID-19, Clinical Competence, Coronavirus Infections diagnosis, Coronavirus Infections epidemiology, Coronavirus Infections psychology, Depression prevention & control, Depression psychology, Emergency Service, Hospital organization & administration, Female, Hospitals, Pediatric organization & administration, Humans, Infection Control instrumentation, Infectious Disease Transmission, Patient-to-Professional prevention & control, Nurses, Pediatric organization & administration, Occupational Exposure adverse effects, Occupational Stress psychology, Personal Protective Equipment, Pneumonia, Viral diagnosis, Pneumonia, Viral epidemiology, Pneumonia, Viral psychology, SARS-CoV-2, Workload psychology, Young Adult, Coronavirus Infections prevention & control, Infection Control organization & administration, Nurses, Pediatric psychology, Occupational Stress prevention & control, Pandemics prevention & control, Pneumonia, Viral prevention & control, Simulation Training organization & administration
- Abstract
Objective: This study aims to discuss the effects of simulation training on improving the pre-examination, triage, prevention, and control of coronavirus disease 2019 (COVID-19), explain the psychological states of pre-examination and triage staff in general hospitals during the COVID-19 epidemic, and analyze relevant influencing factors. This study may serve as a reference of psychological consultation services to medical staff., Subjects and Methods: This study included 60 nurses assigned in the pre-examination department, fever clinics, and isolation wards of a general hospital from January 26th to February 1st, 2020. Before assuming the posts, the nurses received simulation training on the clinical reception of suspected patients with COVID-19. Operation skills of the nurses before and after the training were assessed., Results: The percent of passing significantly increased from 65% before the training to 98.33% after training (p<0.05). Training also significantly relieved the anxiety and depression of the nurses (p<0.05)., Conclusions: Scenario-simulation training can increase the emergency abilities of pediatric nurses in the prevention and control of the COVID-19 epidemic and relieve the anxiety of nurses.
- Published
- 2020
- Full Text
- View/download PDF
9. Effect of dexmedetomidine for sedation and cognitive function in patients with preoperative anxiety undergoing carotid artery stenting.
- Author
-
Wu LP and Kang WQ
- Subjects
- Anxiety drug therapy, Carotid Arteries, Cognition, Humans, Hypnotics and Sedatives therapeutic use, Dexmedetomidine therapeutic use
- Abstract
Objective: This study was performed to examine the effect of dexmedetomidine for intraoperative sedation and postoperative cognitive function in patients with preoperative anxiety undergoing carotid artery stenting., Methods: Eighty patients were randomly divided into two groups: the dexmedetomidine group and the control group. Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Anxiety was evaluated using the Amsterdam Preoperative Anxiety and Information Scale. Routine monitoring indices were recorded during surgery, and cognitive function indices were recorded before drug infusion (T
0 ), 10 minutes after drug infusion (T1 ), at the end of surgery (T2 ), and 6 hours after surgery (T3 )., Results: The anxiety scores were not significantly different between the two groups at T0, but they became significantly different at T1-3 . The MMSE scores in both groups increased at 1 and 7 days postoperatively; although the increase in the dexmedetomidine group was sharper, there was no significant difference. In both groups, the MMSE scores at 1 and 7 days after surgery were not significantly different from those at 1 day before surgery., Conclusion: Dexmedetomidine can improve patients' anxiety and achieve a sufficient sedation effect without causing postoperative cognitive dysfunction.- Published
- 2020
- Full Text
- View/download PDF
10. [Efficacy of heated humidified high-flow nasal cannula in preterm infants aged less than 32 weeks after ventilator weaning].
- Author
-
Kang WQ, Xu BL, Liu DP, Zhang YD, Guo J, Li ZH, Zhou YJ, and Xiong H
- Subjects
- Catheters, Continuous Positive Airway Pressure adverse effects, Female, Humans, Infant, Newborn, Infant, Premature, Male, Noninvasive Ventilation adverse effects, Ventilator Weaning, Noninvasive Ventilation methods
- Abstract
Objective: To investigate the efficacy of heated humidified high-flow nasal cannula (HHHFNC) and nasal continuous positive airway pressure (nCPAP) in preterm infants aged 26-31(+6) weeks with respiratory distress syndrome after ventilator weaning., Methods: A total of 161 preterm infants were randomly divided into two groups after ventilator weaning: HHHFNC treatment (n=79) and nCPAP treatment (n=82). The two groups were subdivided into 26-28(+6) weeks and 29-31+6 weeks groups according to the gestational age. The treatment failure rate, reintubation rate within 7 days after extubation, incidence of complications, and mortality during hospitalization were compared between the two groups., Results: The treatment failure rate and reintubation rate showed no significant differences between the HHHFNC and nCPAP groups. The preterm infants aged 26-28(+6) weeks in the HHHFNC group had a significantly higher treatment failure rate than those in the nCPAP group (P<0.05), while the reintubation rate showed no significant difference. As for the preterm infants aged 29-31(+6) weeks, the treatment failure rate and reintubation rate showed no significant differences between the two groups. The incidence of complications and mortality showed no significant differences between the HHHFNC and nCPAP groups., Conclusions: In preterm infants aged 29-31(+6) weeks, HHHFNC has a similar efficacy as nCPAP after ventilator weaning, while in those aged less than 29 weeks, HHHFNC should be used with great caution if selected as the first-line noninvasive respiratory support.
- Published
- 2016
11. Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial.
- Author
-
Mi GL, Zhao L, Qiao DD, Kang WQ, Tang MQ, and Xu JK
- Subjects
- Humans, Infant, Infant, Newborn, Mothers, Placebos administration & dosage, Random Allocation, Treatment Outcome, Abdominal Pain prevention & control, Abdominal Pain psychology, Colic prevention & control, Colic psychology, Depression prevention & control, Limosilactobacillus reuteri, Probiotics administration & dosage
- Abstract
Infant colic, excessive crying of unknown cause, is a major burden to families and effects about 10-30 % of infants. Despite decades of research, the exact cause and treatment of infant colic has remained elusive. The use of Lactobacillus reuteri (DSM 17938) in infant colic is somewhat controversial and hence, we designed this study to evaluate its efficacy in infantile colic. We recruited predominantly or exclusively breastfed infants, aged less than 4 months in a placebo controlled observational randomized study. Participants' were assigned to receive L. reuteri at a dose 10(8) colony forming units (n = 21) and placebo (n = 21). Placebo was an identical formulation without live micro-organisms. Treatment was given to subjects for 21 days and they were followed for 4 weeks. Treatment success (primary outcome), daily reduction in crying time, parent satisfaction and reduction in maternal depression (secondary outcomes) were assessed at the end of study period. Treatment success was observed in all infants (100 %) of the probiotic group while it was seen in 15.7 % of the placebo group. Mean daily crying time was more significantly reduced to 32.1 ± 8.3 min/day (P < 0.01) from 200.9 ± 6.3 min/day in the probiotic group as compared to the placebo group (120.6 ± 20.0 min/day). Moreover, throughout the study period, parent's satisfaction and improvement in maternal depression (Edinburgh postnatal depression scale) was also significantly higher in the probiotic group. In our study population, reduction in crying time was significant (P < 0.01) even during first week of initiation of therapy. We conclude that L. reuteri (DSM 17938) reduces daily crying time and maternal depression during infantile colic. We suggest L. reuteri may be a safe and efficacious option for reducing infant colic.
- Published
- 2015
- Full Text
- View/download PDF
12. Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes.
- Author
-
Wang YB, Ge ZM, Kang WQ, Lian ZX, Yao J, and Zhou CY
- Abstract
Diabetic cardiomyopathy (DCM), an independent coronary heart disease that develops in diabetic individuals, is characterized by changes in the myocardial structure and function. The aim of the present study was to investigate the protective effect of rutin on DCM in a streptozotocin-induced diabetic rat model. Rutin was orally administrated at a dose of 8 mg/kg body weight. Metabolic profiles, myocardial enzymes and oxidative stress were examined by biochemical tests. The expression levels of cellular proteins associated with apoptosis were measured by western blot analysis, while the levels of inflammatory factors were assessed by immunohistochemical analyses. Rats with DCM exhibited an abnormal metabolic profile, aberrant myocardial enzymes, elevation of oxidative stress markers, increased levels of inflammatory factors and enhanced apoptotic cell death. Notably, rutin was shown to protect and improve myocardial dysfunction, oxidative stress, apoptosis and inflammation in the hearts of the diabetic rats. In conclusion, these results indicated that rutin may have great therapeutic potential in the treatment of DCM, and possibly other cardiovascular disorders, by preventing oxidative stress, inflammation and cell death. However, further detailed studies are required to reveal the exact mechanisms underlying the protective effect of rutin.
- Published
- 2015
- Full Text
- View/download PDF
13. The overexpression of epithelial cell adhesion molecule (EpCAM) in glioma.
- Author
-
Chen X, Ma WY, Xu SC, Liang Y, Fu YB, Pang B, Xin T, Fan HT, Zhang R, Luo JG, Kang WQ, Wang M, and Pang Q
- Subjects
- Adult, Biomarkers, Tumor metabolism, Brain pathology, Brain Neoplasms mortality, Brain Neoplasms pathology, Epithelial Cell Adhesion Molecule, Female, Gene Expression Regulation, Neoplastic, Glioma mortality, Glioma pathology, Humans, Male, Middle Aged, Neovascularization, Pathologic mortality, Neovascularization, Pathologic pathology, Prognosis, Survival Rate, Up-Regulation, Antigens, Neoplasm metabolism, Brain metabolism, Brain Neoplasms metabolism, Cell Adhesion Molecules metabolism, Glioma metabolism, Neovascularization, Pathologic metabolism
- Abstract
Epithelial cell adhesion molecule (EpCAM) is overexpressed in various neoplasms as a tumor-associated antigen and absent in natural brain. However, little is known about EpCAM's expression in gliomas. To investigate the expression of EpCAM in gliomas and understand the correlation of EpCAM expression with malignancy, proliferation, angiogenesis, and prognosis, we studied the expression of EpCAM in 98 glioma samples by immunohistochemistry and by western blotting (N = 12). Correlative analysis of EpCAM overexpression with microvessel density (MVD), Ki-67 expression, age, and gender were made. Survival data was analyzed with Kaplan-Meier method and Cox Proportional Hazard Model. Immunohistochemistry results showed EpCAM was widely expressed in glioma (90.8 %). The overexpression rate of WHO grade IV gliomas was significantly higher EpCAM overexpression correlated significantly with Ki-67 expression and MVD. Western blot analysis also revealed a stepwise increase in EpCAM expression from WHO II to IV glioma. The overall survival of WHO III and IV glioma patients with EpCAM overexpression was obviously lower than that without EpCAM overexpression. EpCAM overexpression was an independent prognostic factor for overall survival in glioma patients. This study firstly shows that EpCAM overexpression correlates significantly with malignancy (WHO grades), proliferation (Ki67), angiogenesis (MVD), and prognosis in gliomas. EpCAM may participate in tumorgenesis of gliomas.
- Published
- 2014
- Full Text
- View/download PDF
14. A novel PITX2c loss‑of‑function mutation underlies lone atrial fibrillation.
- Author
-
Zhou YM, Zheng PX, Yang YQ, Ge ZM, and Kang WQ
- Subjects
- Adult, Alleles, Amino Acid Sequence, Case-Control Studies, Cohort Studies, Exons, Female, Genetic Predisposition to Disease, Heterozygote, Homeodomain Proteins metabolism, Humans, Male, Middle Aged, Molecular Sequence Data, Mutation, Mutation, Missense, Phenotype, Sequence Alignment, Transcription Factors metabolism, Transcriptional Activation, Young Adult, Homeobox Protein PITX2, Atrial Fibrillation genetics, Atrial Fibrillation pathology, Homeodomain Proteins genetics, Transcription Factors genetics
- Abstract
Atrial fibrillation (AF) is the most common form of sustained cardiac arrhythmia responsible for substantial morbidity and significantly increased mortality rates. A growing body of evidence documents the important role of genetic defects in the pathogenesis of AF. However, AF is a heterogeneous disease and the genetic determinants for AF in an overwhelming majority of patients remain unknown. In the present study, a cohort of 100 unrelated patients with lone AF and a total of 200 unrelated, ethnically matched healthy individuals used as controls, were recruited. The whole coding exons and splice junctions of the pituitary homeobox 2c (PITX2c) gene, which encodes a paired‑like homeobox transcription factor required for normal cardiovascular morphogenesis, were sequenced in the 100 patients and 200 control subjects. The causative potential of the identified mutation of PITX2c was predicted by MutationTaster and PolyPhen‑2. The functional characteristics of the PITX2c mutation were assayed using a dual‑luciferase reporter assay system. Based on the results, a novel heterozygous PITX2c mutation (p.T97A) was identified in a patient with AF. The missense mutation was absent in the 400 reference chromosomes and was automatically predicted to be disease‑causing. Multiple alignments of PITX2c protein sequences across species revealed that the altered amino acid was completely conserved evolutionarily. Functional analysis demonstrated that the mutant PITX2c protein was associated with significantly decreased transcriptional activity when compared with its wild‑type counterpart. The findings of the present study firstly link the PITX2c loss‑of‑function mutation to lone AF, and provide novel insight into the molecular mechanisms underlying AF, suggesting the potential implications for the early prophylaxis and allele‑specific therapy of this common type of arrhythmia.
- Published
- 2013
- Full Text
- View/download PDF
15. Elevated lipoprotein-associated phospholipase A2 is associated with progression of nonculprit lesions after percutaneous coronary intervention.
- Author
-
Xin H, Gong HP, Cai SL, Ning XF, Liu S, Chen ZY, Lian ZX, Zhang R, Zhang QF, Kang WQ, and Ge ZM
- Subjects
- Acute Coronary Syndrome pathology, Aged, Anthropometry, Biomarkers blood, Body Mass Index, Cholesterol metabolism, Coronary Angiography, Disease Progression, Female, Follow-Up Studies, Humans, Hydrolysis, Male, Middle Aged, Multivariate Analysis, Oxygen chemistry, Phospholipids chemistry, Time Factors, 1-Alkyl-2-acetylglycerophosphocholine Esterase blood, Acute Coronary Syndrome blood, Acute Coronary Syndrome therapy, Percutaneous Coronary Intervention
- Abstract
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that hydrolyzes oxidized phospholipids to generate bioactive proatherogenic products. Nonculprit lesions have been assumed to contribute to the pathogenesis of recurrent acute coronary syndrome (ACS). The role of LP-PLA2 in the progression of nonculprit coronary lesions after successful percutaneous coronary intervention (PCI) remains unclear. Our study included 123 patients with ACS who underwent initial PCI and a long-term follow-up (mean interval, one year) with coronary angiography. Among them, 19 patients were diagnosed as the progression of nonculprit lesions, based on the presence of at least one of the following factors: (1) ≥ 10% reduction in the diameter of a preexisting ≥ 50% stenosis; (2) ≥ 30% reduction in the diameter of a < 50% stenosis; and (3) early-onset stenosis with ≥ 30% reduction in the diameter of a segment that was normal on the primary angiogram. Blood sampling was drawn from all patients at 12-14 hours after PCI. The ACS patients with progression had higher total cholesterol (4.47 ± 1.02 mmol/L vs. 3.59 ± 0.57 mmol/L, P < 0.05), higher levels of Lp-PLA2 activity (14.39 ± 6.13 nmol/min/ml vs. 8.86 ± 3.14 nmol/min/ml, P < 0.001) and a higher proportion of multi-vessel disease than those without progression. Multivariate logistic regression analysis showed that Lp-PLA2 activity (β = 0.024, P = 0.005) was an independent predictor for rapid progression of nonculprit coronary lesions. In conclusion, elevated Lp-PLA2 activity is associated with rapid progression of nonculprit coronary lesions in ACS patients who underwent PCI.
- Published
- 2013
- Full Text
- View/download PDF
16. Epigallocatechin gallate attenuated the activation of rat cardiac fibroblasts induced by angiotensin II via regulating β-arrestin1.
- Author
-
Han YS, Lan L, Chu J, Kang WQ, and Ge ZM
- Subjects
- Animals, Arrestins antagonists & inhibitors, Arrestins genetics, Catechin pharmacology, Cell Survival drug effects, Cells, Cultured, Collagen metabolism, Fibroblasts cytology, Fibroblasts metabolism, GTP-Binding Protein alpha Subunits, Gq-G11 metabolism, Myocardium cytology, Protein Kinase C-delta metabolism, RNA Interference, RNA, Small Interfering metabolism, Rats, Receptor, Angiotensin, Type 1 genetics, Receptor, Angiotensin, Type 1 metabolism, beta-Arrestins, Angiotensin II pharmacology, Arrestins metabolism, Catechin analogs & derivatives, Fibroblasts drug effects
- Abstract
Background/aims: Angiotensin II (AngII) activated cardiac fibroblasts (CFs) predominantly through AngII subtype 1a receptor (AT1aR). This study was carried out to explore the potential inhibitory effects and mechanisms of epigallocatechin gallate (EGCG) on AngII induced rat CFs., Methods: Viability, proliferation and collagen production of CFs were measured by MTT assay, [3H]-thymidine and [3H]-proline incorporation respectively. β-arrestin1 (βarr1), AT1aR and AT1bR mRNA levels were determined by quantitative PCR. AT1R, Gq, βarr 1/2, phosphorylated kinase C (p-PKC)-delta expressions were detected by western blotting. We blocked βarr1 expression using βarr1 small interfering RNA (siRNA)., Results: EGCG inhibited the activation of CFs induced by AngII. βarr1 mRNA level revealed a positive correlation with the viability of CFs. SiRNA targeting βarr1 blocked the activation of CFs. In vitro, AngII increased βarr1 mRNA, total and membrane βarr1 protein expressions, but reduced AT1aR mRNA, global and membrane AT1R, total Gq and cytoplasmic p-PKC-delta levels. Administration of EGCG restored the above abnormalities, whereas Gq levels were not affected., Conclusion: Our findings showed that βarr1 is essential for AngII-mediated activation of CFs. EGCG attenuated CFs activation induced by AngII via regulating βarr1 and thus, modulating AT1aR mediated signaling.
- Published
- 2013
- Full Text
- View/download PDF
17. [Clinical results of ultrasound biometry in silicone oil-filled eye].
- Author
-
Liu GJ, Shen BL, Qiu YJ, Yu Z, Cui HS, Wang HC, Kang WQ, and Liu Y
- Subjects
- Adolescent, Adult, Aged, Child, Female, Humans, Male, Middle Aged, Ultrasonography, Young Adult, Biometry methods, Eye diagnostic imaging, Lenses, Intraocular, Silicone Oils
- Abstract
Objective: To evaluate a method of ultrasound biometry in silicone oil-filled eye and its clinical results., Methods: This was a series case study. According to the principle of measuring a distance with ultrasound, we compared the measured distance between a space filed with balanced salt solution and silicone oil at same height, to calculate a conversion factor (0.674) between them. A formula for corrective axial length in silicone oil-filled eye was established. The formula = ab + 0.674 x bc (a, b and c standing for the apex of the cornea, the posterior pole of the lens or the center of the capsular membrane and the anterior surface of the macular, respectively). The axial lengths of 150 silicone oil-filled eyes in 150 cases were then measured before and after silicone oil removal with Vivid 7 Dimension ultrasound. According to the axial length, they were divided into two groups, namely group 1 (the length < 25 mm) and group 2 (the length > or = 25 mm). In 76/150 eyes, before combined silicone oil removal and intraocular lens (IOL) implantation, the SRKT formula was used for intraocular lens calculation; the post-operative actual refraction was compared with the pre-operative predicted refraction and statistics analysis was made., Results: The retinal condition of 150 silicone oil-filled eyes in 150 cases after 3 months' follow-up was stable after surgery. The results of the biometry were as follows. In the first group, the mean corrective axial lengths of 111 silicone oil-filled eyes before silicone oil removal was (22.77 +/- 1.00) mm (ranging from 21.10 to 24.90 mm); the mean axial lengths after silicone oil removal was (22.76 +/- 0.99) mm (ranging from 21.00 to 24.70 mm). The difference between them was not statistically significant (t = 0.518, P > 0.05). The vitreous cavity depth before and after silicone oil removal was (26.57 +/- 2.14) mm and (17.90 +/- 1.38) mm, respectively. The ratio of the latter to the former was 0.673 78. In the second group, the mean corrective axial lengths of 39 silicone oil-filled eyes before silicone oil removal was (26.52 +/- 1.31) mm (ranging from 25.00 to 30.58 mm); the mean axial lengths after silicone oil removal was (26.53 +/- 1.29) mm (ranging from 25.00 to 30.59 mm). The difference between them was not statistically significant (t = 0.109, P > 0.05). The vitreous cavity depth before and after silicone oil removal was (32.01 +/- 2.90) mm and (21.57 +/- 2.04) mm, respectively. The ratio of the latter to the former was 0.673 95. In 76 eyes with IOL, the post-operative actual refraction after at least 3 months follow-up was compared with the pre-operative predicted refraction (-1.50 DS) in both groups. The differences between them were not statistically significant (t(1) = 0.253, P(1) > 0.05; t(2) = 0.209, P(2) > 0.05) in each group., Conclusion: Ultrasound biometry in silicone oil-filled eye is accurate and simple, and has good results in clinical measurement.
- Published
- 2010
18. Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina.
- Author
-
Zhao Z, Geng J, Ge ZM, Wang W, Zhang Y, and Kang WQ
- Subjects
- Aged, 80 and over, Angina, Unstable blood, Anti-Inflammatory Agents adverse effects, Anti-Inflammatory Agents therapeutic use, Anticholesteremic Agents adverse effects, Anticholesteremic Agents therapeutic use, Atorvastatin, Dose-Response Relationship, Drug, Endothelium, Vascular drug effects, Endothelium, Vascular physiology, Female, Humans, Inflammation Mediators blood, Length of Stay, Lipids blood, Male, Middle Aged, Treatment Outcome, Aged, Angina, Unstable drug therapy, Heptanoic Acids adverse effects, Heptanoic Acids therapeutic use, Hospitalization, Pyrroles adverse effects, Pyrroles therapeutic use
- Abstract
1. Previous studies have demonstrated that early statin therapy after acute coronary syndrome decreases inflammation and mortality rates. The dose-response relationship for atorvastatin in elderly patients with unstable angina (UA) during early hospitalization in terms of lowering inflammatory factors, improving vascular endothelium function and safety is unclear. 2. In the present study, 166 consecutive patients with UA who were >/= 60 years of age were randomly assigned, in a double-blind manner, to receive 80 or 20 mg/day atorvastatin. High-sensitivity C-reactive protein, interleukin-6, tumour necrosis factor-alpha, fibrinogen and lipid levels were measured at admission and 1, 2 and 8 weeks later. Vascular endothelial function was measured and the safety of the drug was monitored. 3. Levels of inflammatory factors were significantly lower in patients on 80 mg atorvastatin than in those on 20 mg atorvastatin at 2 and 8 weeks. Atorvastatin 80 mg not only resulted in a significant improvement in vascular endothelial function during early hospitalization for UA over that seen in patients on 20 mg atorvastatin, but also reduced lipid levels to a greater extent. At 8 weeks, almost all patients showed good tolerance of 80 mg/day atorvastatin. 4. The results of the present study indicate that intensive statin therapy with high-dose (80 mg/day) atorvastatin is more efficacious than and as safe as 20 mg/day atorvastatin when administered to elderly patients during early hospitalization for UA.
- Published
- 2009
- Full Text
- View/download PDF
19. Relationship between tissue type plasminogen activator and coronary vulnerable plaque in patients with acute coronary syndrome: virtual histological study.
- Author
-
Wang HB, Kang WQ, Song DL, Wang X, Ren GR, Teng JL, and Ge ZM
- Subjects
- Acute Coronary Syndrome pathology, Aged, Female, Humans, Male, Middle Aged, Ultrasonography, Interventional, Acute Coronary Syndrome blood, Coronary Artery Disease pathology, Coronary Vessels pathology, Tissue Plasminogen Activator blood
- Abstract
Background: The association between vulnerability of plaque assessed with intravascular ultrasound (IVUS) and plasma levels of fibrinolytic biomarkers was determined in patients with acute coronary syndrome (ACS). However, few data are available on the relationship between the levels of tissue type plasminogen activator (t-PA) and virtual histological intravascular ultrasound (VH-IVUS) signs of plaque instability., Methods: Eighty-nine patients with ACS were enrolled in the study. Blood was collected to measure t-PA levels by liquid phase bead flow cytometry. Eighty-nine nonbifurcate lesions (identified by coronary angiography and ECG) were investigated using IVUS before catheterization. IVUS radiofrequency data obtained with a 20 MHz catheter were analyzed with IVUS virtual histological software. The areas of plaque and media were calculated and lesions were classified into two groups: VH-IVUS derived thin cap fibroatheroma (VH-TCFA) and non-VH-TCFA plaque., Results: Plasma t-PA level in the patients with TCFA was significantly lower than that with non-TCFA ((1489+/-715) pg/ml vs (2163+/-1004) pg/ml). Decreased plasma levels of t-PA were associated with plaque vulnerability. Plasma levels of t-PA correlated negatively with plaque plus media and necrotic core in plaque in patients with ACS., Conclusions: t-PA is an independent risk factor and a powerful predictor of vulnerable plaques. Decreased levels of t-PA may reflect instability of atherosclerotic plaques and might therefore serve as noninvasive determinants of those at high risk for consequent adverse events.
- Published
- 2008
20. [Relationship between serum vasoactive factors and plaque morphology in patients with acute coronary syndrome].
- Author
-
Kang WQ, Song DL, and Guo XG
- Subjects
- Acute Coronary Syndrome blood, Adult, Aged, Biomarkers, CD40 Ligand blood, Chemokine CCL2 blood, Female, Humans, Male, Middle Aged, P-Selectin blood, Acute Coronary Syndrome pathology, C-Reactive Protein metabolism, Interleukin-6 blood
- Abstract
Objective: To investigate the relationship between vasoactive factors and plaque morphology in patients with acute coronary syndrome (ACS)., Methods: Intravascular ultrasound (IVUS) were performed and 7 serum vasoactive factors (sPE, tPA, MCP-1, IL-8, IL-6, sVCAM-1 and sCD40L) were measured through cytometric bead array, serum hs-CRP, HCY, glucose and lipid level were also determined in consecutively enrolled 56 patients with ACS. The changes of bio-factors were compared between vulnerable plaque and non-vulnerable plaque groups, AMI and UA patients, and patients with or without plaque rupture., Results: Biomarkers were similar between patients with unstable angina pectoris and AMI. hs-CRP [(18.9 +/- 4.9) mg/l vs. (5.8 +/- 3.6) mg/L)] and IL-6 [19.5 pg/ml (9.2 - 44.6 pg/ml) vs. 5.3 pg/ml (2.3 - 13.4 pg/ml)] were significantly higher in the group of vulnerable plaque (P < 0.05) compared to non-vulnerable plaques group. sCD40L [(474 +/- 126) pg/ml vs. (238 +/- 35) pg/ml], sPE [(107.2 +/- 39.9) microg/ml vs. (49.1 +/- 5.6) microg/ml] and MCP-1 [(132 +/- 18) pg/ml vs. (127 +/- 13) pg/ml] were significantly increased in the plaque rupture group than that in non-plaque rupture group (all P < 0.05). Increasing of sCD40L, MCP-1, sPE and TC were independent risk factors for plaque rupture., Conclusions: IL-6 and hs-CRP are biomarkers for vulnerable plaques and diagnosis of acute myocardial infarction. sCD40L, MCP-1 and sPE may serve as the potential markers predicting plaque rupture in patients with ACS.
- Published
- 2007
21. The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts.
- Author
-
Dai HY, Kang WQ, Wang X, Yu XJ, Li ZH, Tang MX, Xu DL, Li CW, Zhang Y, and Ge ZM
- Subjects
- Animals, Animals, Newborn, Cells, Cultured, Fibroblasts cytology, Fibroblasts drug effects, Gene Expression drug effects, Myocardium cytology, Myocardium metabolism, Peptide Fragments pharmacology, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Rats, Wistar, Receptors, G-Protein-Coupled antagonists & inhibitors, Receptors, G-Protein-Coupled metabolism, Reverse Transcriptase Polymerase Chain Reaction, Transforming Growth Factor beta1 genetics, Collagen metabolism, Fibroblasts metabolism, Transforming Growth Factor beta1 metabolism, Urotensins pharmacology
- Abstract
As the most potent vasoconstrictor in mammals, urotensin II (U II) has recently been demonstrated to play an important role in adverse cardiac remodeling and fibrosis. However, the mechanisms of U II-induced myocardial fibrosis remain to be clarified. We postulated that U II alters transforming growth factor-beta1 (TGF-beta1) expression, and thereby modulates cardiac fibroblast collagen metabolism. Experiments were conducted using cardiac fibroblast from neonatal Wistar rats to determine the expression of TGF-beta1, and the role of U II receptor UT in this process. The functional role of TGF-beta1 and UT in modulating U II effects on type I, III collagen mRNA expression and 3H-proline incorporation was also analyzed. TGF-beta1 gene and protein expression were consistently identified in quiescent cardiac fibroblasts. U II increased the expression of TGF-beta1 mRNA and protein in a time-dependent manner. This effect was UT mediated, because UT antagonist urantide abolished U II-induced TGF-beta1 expression. U II-induced increase in type I, III collagen mRNA expression and 3H-proline incorporation were both inhibited by a specific TGF-beta1 neutralizing antibody and UT receptor antagonist urantide. Hence, our results indicate that TGF-beta1 is upregulated in cardiac fibroblasts by U II via UT and modulates profibrotic effects of U II. These findings provide novel insights into U II-induced cardiac remodeling.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.